MX2018006575A - Composiciones y metodos para profilaxis otologica y tratamiento. - Google Patents
Composiciones y metodos para profilaxis otologica y tratamiento.Info
- Publication number
- MX2018006575A MX2018006575A MX2018006575A MX2018006575A MX2018006575A MX 2018006575 A MX2018006575 A MX 2018006575A MX 2018006575 A MX2018006575 A MX 2018006575A MX 2018006575 A MX2018006575 A MX 2018006575A MX 2018006575 A MX2018006575 A MX 2018006575A
- Authority
- MX
- Mexico
- Prior art keywords
- otitis media
- ear
- acute
- middle ear
- chronic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
- 230000001154 acute effect Effects 0.000 abstract 3
- 206010033078 Otitis media Diseases 0.000 abstract 2
- 210000000959 ear middle Anatomy 0.000 abstract 2
- 206010011878 Deafness Diseases 0.000 abstract 1
- 206010063045 Effusion Diseases 0.000 abstract 1
- 206010015543 Eustachian tube dysfunction Diseases 0.000 abstract 1
- 208000005141 Otitis Diseases 0.000 abstract 1
- 206010045210 Tympanic Membrane Perforation Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000024035 chronic otitis media Diseases 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 208000019258 ear infection Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001667 episodic effect Effects 0.000 abstract 1
- 210000002388 eustachian tube Anatomy 0.000 abstract 1
- 230000010370 hearing loss Effects 0.000 abstract 1
- 231100000888 hearing loss Toxicity 0.000 abstract 1
- 208000016354 hearing loss disease Diseases 0.000 abstract 1
- 208000005923 otitis media with effusion Diseases 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 238000011477 surgical intervention Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000009423 ventilation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe un método profiláctico para prevenir la otitis media o la disfunción del tubo de Eustaquio, o para reducir la severidad de los síntomas de la misma, disminuyendo el riesgo de otitis media futura, con o sin la infección del oído, y los efectos asociados, que incluyen la pérdida aguda o permanente de la audición, problemas en el habla y en el equilibrio, problemas en la conducta y problemas del sueño provocados por la otitis media aguda, intermitente en episodios, recurrente o crónica, y la necesidad para intervenciones quirúrgicas que involucran la miringotomía tales como los tubos de oído para los derrames crónicos del oído medio, o la perforación de la membrana timpánica para el drenado agudo del derrame proveniente del oído medio y la ventilación del oído medio, a través de la administración nasal del tensioactivo al o a los tubos de Eustaquio.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562260742P | 2015-11-30 | 2015-11-30 | |
| US201562260732P | 2015-11-30 | 2015-11-30 | |
| US201562260734P | 2015-11-30 | 2015-11-30 | |
| PCT/US2016/064190 WO2017095905A1 (en) | 2015-11-30 | 2016-11-30 | Compositions and methods for otologic prophylaxis and treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018006575A true MX2018006575A (es) | 2018-12-06 |
Family
ID=58778000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018006575A MX2018006575A (es) | 2015-11-30 | 2016-11-30 | Composiciones y metodos para profilaxis otologica y tratamiento. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20170151173A1 (es) |
| EP (1) | EP3383369A4 (es) |
| JP (1) | JP2018535277A (es) |
| KR (1) | KR20180105129A (es) |
| AU (1) | AU2016365219A1 (es) |
| CA (1) | CA3006563A1 (es) |
| MX (1) | MX2018006575A (es) |
| WO (1) | WO2017095905A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020142420A1 (en) * | 2018-12-31 | 2020-07-09 | Novus Therapeutics, Inc. | Novel surfactant-lipid alloy drug substance, methods of making the same, and pharmaceutical compositions comprising the same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997029738A1 (en) * | 1996-02-16 | 1997-08-21 | The Administrators Of The Tulane Educational Fund | Methods and compositions for treating eustachian tube dysfunction by inhalation |
| US5954682A (en) * | 1996-09-25 | 1999-09-21 | Advanced Medical Instruments | Therapeutic applicator apparatus and method |
| CO4910145A1 (es) * | 1996-10-01 | 2000-04-24 | Smithkline Beecham Corp | Uso |
| KR20010032435A (ko) * | 1997-11-24 | 2001-04-25 | 데이비드 엠 모이어 | 5-(2-이미다졸리닐아미노)벤즈이미다졸 유도체, 그의 제조및 대사 안정성이 개선된 알파-아드레날린수용체아고니스트로서의 그의 용도 |
| US6676930B2 (en) * | 1999-11-28 | 2004-01-13 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| US6156294A (en) * | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| US20060207596A1 (en) * | 2005-03-18 | 2006-09-21 | Fairfield Clinical Trials, Llc | Device and method for delivery of combination nasal medication |
| EP2040721B1 (en) * | 2006-05-31 | 2013-05-08 | Medihoney Pty Ltd | Medicinal compositions containing honey |
| US8343464B2 (en) * | 2010-04-30 | 2013-01-01 | Burns Phillip E | Composition and method for treating eustachian tube dysfunction |
| KR102240042B1 (ko) * | 2012-05-03 | 2021-04-14 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형 |
| CA2877941A1 (en) * | 2012-06-29 | 2014-01-03 | Microdose Therapeutx, Inc. | Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
-
2016
- 2016-11-30 JP JP2018547866A patent/JP2018535277A/ja active Pending
- 2016-11-30 WO PCT/US2016/064190 patent/WO2017095905A1/en active Application Filing
- 2016-11-30 MX MX2018006575A patent/MX2018006575A/es unknown
- 2016-11-30 AU AU2016365219A patent/AU2016365219A1/en not_active Abandoned
- 2016-11-30 US US15/365,321 patent/US20170151173A1/en not_active Abandoned
- 2016-11-30 KR KR1020187018607A patent/KR20180105129A/ko unknown
- 2016-11-30 EP EP16871410.3A patent/EP3383369A4/en not_active Withdrawn
- 2016-11-30 CA CA3006563A patent/CA3006563A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170151173A1 (en) | 2017-06-01 |
| EP3383369A4 (en) | 2019-06-12 |
| AU2016365219A1 (en) | 2018-07-05 |
| JP2018535277A (ja) | 2018-11-29 |
| EP3383369A1 (en) | 2018-10-10 |
| KR20180105129A (ko) | 2018-09-27 |
| WO2017095905A1 (en) | 2017-06-08 |
| CA3006563A1 (en) | 2017-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014120499A3 (en) | Respirator mask speech enhancement apparatus and method | |
| EP3580604A4 (en) | METHODS, DEVICES AND SYSTEMS FOR FOCUS ADJUSTMENT OF DISPLAYS | |
| ZA202002652B (en) | Alpha-1 antitrypsin (aat) rnai agents, compositions including aat rnai agents, and methods of use | |
| DK3743777T3 (da) | Systemer og fremgangsmåder til aktiv justering af uklarhedspunkt og kølekredsløb | |
| BR112015019498A2 (pt) | protetor de ouvido com cavidade de ponta e métodos de fabricação do mesmo | |
| DK3588985T3 (da) | Binauralt høreapparatsystem med binaural aktiv okklusionsafbrydelse | |
| PH12018500047A1 (en) | Notch pathway signaling inhibitor compounds | |
| MX2019005934A (es) | Compuestos de benzodiazolio como inhibidores del canal de sodio epitelial (enac). | |
| WO2015181251A3 (de) | Vorrichtung und methode zur prävention einer schwerhörigkeit oder gleichgewichtsstörung | |
| CO6450663A2 (es) | Composiciones óticas útiles para el tratamiento de infeciones del oído interno y externo en mamíferos | |
| DK3468228T3 (da) | Binauralt høresystem med lokalisering af lydkilder | |
| DK3520441T3 (da) | Aktiv undertrykkelse af okklusionseffekten i hørehjælpemidler | |
| EA201891834A1 (ru) | Способы и устройства для уменьшения повреждающих эффектов сильного удара или воздействий, вызывающих сотрясение, у субъекта | |
| DK3134094T3 (da) | Anordning til behandling af, behandling af komplikationer som følge af og/eller forebyggelse af luftvejssygdomme forårsaget af infektioner med bakterier, virus, protozoer, svampe og/eller mikrober, (...) | |
| PH12018502154A1 (en) | Methods of treating ocular conditions | |
| MX361505B (es) | Sistema de lentes de contacto con comodidad optimizada para la aberración ocular sin simetría rotacional. | |
| EP3841219A4 (en) | ASYMMETRICAL TARGETED AMPLIFICATION METHODS | |
| MX2018006575A (es) | Composiciones y metodos para profilaxis otologica y tratamiento. | |
| EP3773381A4 (en) | SYSTEMS AND METHODS FOR PERFORMING A TRANSCHANNEL OHROPERATION | |
| WO2012031123A3 (en) | Method of treating ear infections | |
| DK3373600T3 (da) | Hørehjælpeindretning til kompensering af tinnitus | |
| EP3634200A4 (en) | STABILIZATION OF AURICULAR DEVICES | |
| EA201800565A1 (ru) | Композиция для лечения заболеваний уха, содержащая (+)-азасетрон | |
| MX2022000311A (es) | Formas cristalinas de inhibidores de calicreina plasmatica. | |
| EP3752140A4 (en) | PROCEDURES AND COMPOSITIONS TO PREVENT, REDUCE OR ELIMINATE TOXICITY CAUSED BY ACETAMINOPHEN (APAP) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: NOVUS THERAPEUTICS, INC. |